RN7SL850P

Across TCGA pan-cancer cohorts, RN7SL850P RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RN7SL850P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RN7SL850P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RN7SL850P expression acts as an unfavorable survival marker, although some lineages such as MESO and SKCM show a favorable association.

MESO, SKCM, and KIRC are the cancer types where RN7SL850P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Quartile	II,III,IV	0.802	0.497	.004	102	view →
SKCM	OS	Median	III,IV	0.878	0.721	.002	58	view →
KIRC	DFS	Quartile	II,III,IV	0.185	0.574	<.001	36	view →
UVM	DFS	Tertile	All	0.312	0.629	.009	36	view →
KIRP	DFS	Quartile	All	0.437	0.683	<.001	34	view →
COAD	DFS	Tertile	III,IV	0.183	0.610	.003	19	view →
KICH	DFS	Tertile	III,IV	0.043	0.897	.045	9	view →
READ	DFS	Tertile	IV	0.179	0.936	.010	9	view →
BRCA	OS	Quartile	III,IV	0.330	0.635	.004	8	view →
OV	DFS	Tertile	IV	0.375	0.548	.037	6	view →
THCA	OS	Quartile	IV	0.872	1.000	.012	6	view →
LUAD	DFS	Median	IV	0.304	0.706	.037	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RN7SL850P–MESO (OS)

Open the MESO breakdown →